Authors:
BERETTA A
WEISS SH
RAPPOCCIOLO G
MAYUR R
DESANTIS C
QUIRINALE J
COSMA A
ROBBIONI P
SHEARER GM
BERZOFSKY JA
VILLA ML
SICCARDI AG
CLERICI M
Citation: A. Beretta et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SERONEGATIVE INJECTION-DRUG USERS AT RISK FOR HIV EXPOSURE HAVE ANTIBODIES TO HLA CLASS-I ANTIGENS AND T-CELLS SPECIFIC FOR HIV ENVELOPE, The Journal of infectious diseases, 173(2), 1996, pp. 472-476
Authors:
WEISS SH
DENNY TN
QUIRINALE J
MAYUR RK
PALUMBO PE
HEREDIA A
COWAN EP
HEWLETT I
MCCREEDY BJ
Citation: Sh. Weiss et al., HTLV-II SCREENING ISSUES - FALSE-NEGATIVE HTLV ELISA RESULTS WITHIN AHIGH-RISK IDU COHORT, AIDS research and human retroviruses, 10(4), 1994, pp. 451-451
Authors:
HEREDIA A
JOSHI B
WEISS SH
LEE SF
MULLER J
POFFENBERGER KL
QUIRINALE J
EPSTEIN JS
HEWLETT IK
Citation: A. Heredia et al., ABSENCE OF EVIDENCE OF RETROVIRUS INFECTION IN INTRAVENOUS-DRUG-USERSWITH IDIOPATHIC CD4+ LYMPHOCYTOPENIA, The Journal of infectious diseases, 170(3), 1994, pp. 748-749
Citation: Sh. Weiss et al., SAFE SEX QUESTIONABLE MISCONCEPTIONS, GENDER DIFFERENCES AND BARRIERSAMONG INJECTION-DRUG USERS - A FOCUS GROUP-APPROACH, AIDS education and prevention, 5(4), 1993, pp. 279-293